Insider filing
Traded Jan 5 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 9, 2025 · Filed Dec 10, 2025
A Hims & Hers Health director sold $98K of Hims & Hers Health shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$97,925
Shares × reported transaction price
36 days after results of Nov 3, 2025, 76 days before results of Feb 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $39.82 on Dec 9, 2025, 65% above its 52-week low and 42% below its high, after a 17% drop over the previous 30 trading days
52-week range $24.18 (Dec 31, 2024) to $68.74 (Feb 19, 2025), 35% of the way up, from 250 adjusted closes. 30 trading days earlier: $48.23 on Oct 27, 2025. Describes the past only, not a forecast
RSI 49, 13% under its 200-day average, 12% under its 50-day average, 42% below the 52-week high, 20-day volatility 70% a year, against the S&P 500: −5 points over 1 month, −21 points over 3 months, −41 points over 6 months
From the adjusted closes up to Dec 9, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.9% | −1.8% | −6.1% |
| 30 days | −14.4% | +0.9% | −15.3% |
| 90 days | −31.5% | −1.9% | −29.6% |
| 180 days | −23.3% | +7.0% | −30.2% |
Past results only. Not a forecast.
Insider filing
Traded Jan 5 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Jan 5 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Oluyemi Okupe (Chief Financial Officer) sold ~$306K of Hims & Hers Health
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.